![Nicholas Cross](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Cross
Presidente en
Accession Therapeutics Limited
.
Perfil
Nicholas Cross is the founder of Immunocore Holdings Plc, which was founded in 2008.
He is currently the Executive Chairman at Accession Therapeutics Limited.
Mr. Cross was formerly the Chairman at Oxford Asymmetry International Plc, Director at Avidex Ltd. from 2006 to 2008, and Non-Executive Director at Oxxon Therapeutics, Inc.
Cargos activos de Nicholas Cross
| Empresas | Cargo | Inicio |
|---|---|---|
Accession Therapeutics Limited
 Accession Therapeutics Limited BiotechnologyHealth Technology Develops novel immuno-oncology therapeutics | Presidente | - |
Antiguos cargos conocidos de Nicholas Cross.
| Empresas | Cargo | Fin |
|---|---|---|
Avidex Ltd.
 Avidex Ltd. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs for the treatment of cancer and autoimmune diseases | Director/Miembro de la Junta | 04/12/2008 |
| IMMUNOCORE HOLDINGS PLC | Fundador | - |
Oxford Asymmetry International Plc
 Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs | Presidente | - |
Oxxon Therapeutics, Inc.
 Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures antigen-specific immunotherapy’s to treat patients | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
13
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Oxford Asymmetry International Plc
Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs | Process Industries |
Avidex Ltd.
Avidex Ltd. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs for the treatment of cancer and autoimmune diseases | Health Technology |
Oxxon Therapeutics, Inc.
Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures antigen-specific immunotherapy’s to treat patients | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Accession Therapeutics Limited
Accession Therapeutics Limited BiotechnologyHealth Technology Develops novel immuno-oncology therapeutics | Health Technology |
- Bolsa de valores
- Insiders
- Nicholas Cross
